We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Algorithm Monitors Vital Signs and Lab Results to Detect Sepsis before Symptom Onset

By HospiMedica International staff writers
Posted on 25 Jan 2024

Sepsis, a serious blood infection, can initiate a life-threatening chain reaction throughout the body and poses a significant global health challenge. More...

As a dysregulated host response to infection, sepsis affects over 48.9 million people annually worldwide, resulting in approximately 11 million deaths. Early detection of sepsis is crucial for effective treatment, including fluid resuscitation, antibiotic administration, and source control. However, identifying sepsis can be difficult due to its heterogeneous nature. Algorithms designed to aid early sepsis recognition could potentially enhance patient outcomes, yet there is limited research on their real-world impact.

At UC San Diego Health (San Diego, CA, USA), researchers have developed an AI model named COMPOSER to rapidly identify patients at risk of sepsis. This model leverages real-time data to predict sepsis before clear clinical signs emerge. Operating discreetly, COMPOSER continually monitors each patient from the moment they enter the emergency department, analyzing over 150 variables linked to sepsis, including lab results, vital signs, medications, demographics, and medical history. The advanced AI algorithms in COMPOSER can detect subtle patterns not immediately apparent to clinicians. By evaluating these risk factors, the system generates highly accurate sepsis predictions.

Should a patient exhibit a combination of high-risk factors for sepsis, COMPOSER alerts the nursing staff through the hospital’s electronic health record. The nurses then collaborate with physicians to decide the best course of action. If the algorithm determines that the risk patterns are more likely attributed to other conditions, it does not send an alert. Since its activation in December 2022, COMPOSER has been implemented in various in-patient units at UC San Diego Health. A study involving over 6,000 patient admissions before and after deploying COMPOSER in UC San Diego Medical Center and Jacobs Medical Center emergency departments revealed a 17% reduction in mortality, marking the first reported instance of improved patient outcomes through an AI deep-learning model.

“It is because of this AI model that our teams can provide life-saving therapy for patients quicker,” said study co-author Gabriel Wardi, MD, chief of the Division of Critical Care in the Department of Emergency Medicine at UC San Diego School of Medicine.

Related Links:
UC San Diego Health


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.